MaxCyte Statistics
NASDAQ: MXCTHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
1.04-0.05 (-4.59%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
MaxCyte by the numbers
MaxCyte has a market capitalization of $107.3 million based on 103.21M shares outstanding. With trailing EPS of $-0.34, MaxCyte is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 13.8% below its 50-day average and 3.5% below its 200-day average.
Average daily trading volume is 699.83K shares, or about $727,819 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MXCT valuation vs. peer median
| Metric | MXCT | Peer median | Difference |
|---|---|---|---|
| Market cap | $107.33M | $28.60M | +275% |
| Avg. volume | 699.83K | 671.16K | +4% |
Peer median across 5 companies: ONMD, BIAF, ISPC, NRC, OABI.
Valuation
- Market cap
- $107.33M
- EPS (TTM)
- $-0.34
- Shares outstanding
- 103.21M
Price and trading
- Previous close
- 1.09
- Open
- 1.07
- Day range
- 1.04 – 1.08
- 52-week range
- 0.643 – 1.87
- 52-week change
- -32.90%
- Beta
- —
- Volume
- 311.84K
- Average volume
- 699.83K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 12, 2026
Additional statistics
- Market Cap
- 107.33M
- Forward Pe
- -4.24
- Eps
- -0.34
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1.87
- Week52 Low
- 0.64
- Avg Volume
- 699.83K
- Shares Outstanding
- 103.21M
- Ma50
- 1.21
- Ma200
- 1.08
- Earnings Date
- Aug 12, 2026
- Pct From52w High
- -44.24%
- Pct From52w Low
- 61.74%